Intraperitoneal Alfaxalone and Alfaxalone–Dexmedetomidine Anesthesia in Sprague–Dawley Rats (Rattus norvegicus)

Webinar — Choosing the Right CDMO for your Highly Potent Product Development

Altasciences CDMO facility is equipped with a 2,000-square-foot GMP high-potency/Grade C manufacturing and handling area paired with state-of-the-art fully qualified equipment and is managed by our highly trained team of experts.

Watch this on-demand webinar to know more about our potent handling capabilities.

WEBINAR — A Guide to Interpreting the Certificate of Analysis

Reference standards are required for regulated bioanalysis, and the quality and degree of characterization of the reference standard will depend on the stage of drug development. To evaluate if all requirements are met, it is important to understand the information provided within a reference standard certificate of analysis (CoA).

.custom-column-left-text { float: left; width: 50%; padding-right: 10px; } .custom-column-right-text { float: right; width: 45%; text-align:center; } @media only screen and (max-width: 600px) { .custom-column-left-text, .custom-column-right-text, .custom-column-flc-ebook-text { float:none; width:80%; margin:0 auto; } }

An important consideration in choosing a research partner for your drug development programs is their experience and expertise in managing their study sites.

Subscribe to